Utility calculator for visual acuity
datasetposted on 18.09.2019, 13:23 by Rebekah Pennington, Monica Hernandez, Philip Hykin, Sobha Sivaprasad, Laura Flight, Abualbishr Alshreef, John Brazier
Please see readme.txt
A multicentre double-masked randomised non-inferiority clinical trial comparing the clinical and cost-effectiveness of intravitreal ranibizumab (Lucentis), aflibercept (Eylea) and bevacizumab (Avastin) for Macular Oedema due to Central Retinal Vein Occlusion (acronym: LEAVO)
NIHR Evaluation Trials and Studies Coordinating CentreFind out more...